http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 28 May 2026 20:31:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++144++++++++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Mossler+Mark/26569399.html si-local-file:///var/storage/secattach/20260528/26569399.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Mossler+Mark/26569399.html Thu, 28 May 2026 20:31:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++144++++++++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Mossler+Mark/26569399.html si-local-file:///var/storage/secattach/20260528/26569399.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Mossler+Mark/26569399.html Thu, 28 May 2026 20:31:00 -0400 CCCC O.48629524 http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Press+Releases/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html <p>WATERTOWN, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in the upcoming conferences.</p> <p><strong>TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &amp; EHA</strong></p> <ul type="disc"><li>Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.<br/><br/></li></ul> <p><strong>2026 Jefferies Global Healthcare Conference</strong></p> <ul type="disc"><li>Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.<br/><br/></li></ul> http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+to+Participate+in+Upcoming+Conferences/26524632.html Wed, 20 May 2026 07:00:00 -0400 A.50100012 CCCC O.07579093 O.48629524 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Squadron+Capital+Management+LLC/26521190.html si-local-file:///var/storage/secattach/20260519/26521190.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Squadron+Capital+Management+LLC/26521190.html Tue, 19 May 2026 16:09:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Squadron+Capital+Management+LLC/26521190.html si-local-file:///var/storage/secattach/20260519/26521190.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Squadron+Capital+Management+LLC/26521190.html Tue, 19 May 2026 16:09:00 -0400 CCCC O.48629524 http://www.streetinsider.com/Press+Releases/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html <p>WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 85,480 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the grant made on May 18, 2026 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering employment with C4T in accordance with http://www.streetinsider.com/Press+Releases/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html Mon, 18 May 2026 16:01:00 -0400 CCCC O.48629524 http://www.streetinsider.com/Press+Releases/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html <p>WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 85,480 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the grant made on May 18, 2026 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering employment with C4T in accordance with http://www.streetinsider.com/Press+Releases/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html Mon, 18 May 2026 16:01:00 -0400 CCCC O.48629524 http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html <p>WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 85,480 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the grant made on May 18, 2026 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering employment with C4T in accordance with http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html Mon, 18 May 2026 16:01:00 -0400 CCCC O.48629524 http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html <p>WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the independent directors serving on the Organization, Leadership and Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 85,480 shares of the Company’s common stock to one new employee (the “Inducement Grant”), with the grant made on May 18, 2026 (the “Grant Date”). The Inducement Grant was granted as a material inducement to this individual entering employment with C4T in accordance with http://www.streetinsider.com/Globe+Newswire/C4+Therapeutics+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26513536.html Mon, 18 May 2026 16:01:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506223.html si-local-file:///var/storage/secattach/20260515/26506223.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506223.html Fri, 15 May 2026 16:29:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506223.html si-local-file:///var/storage/secattach/20260515/26506223.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Point72+Asset+Management%2C+L.P./26506223.html Fri, 15 May 2026 16:29:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++C4+Therapeutics%2C+Inc.+++++For%3A+May+15/26504897.html si-local-file:///var/storage/secattach/20260515/26504897.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++C4+Therapeutics%2C+Inc.+++++For%3A+May+15/26504897.html Fri, 15 May 2026 16:05:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++C4+Therapeutics%2C+Inc.+++++For%3A+May+15/26504897.html si-local-file:///var/storage/secattach/20260515/26504897.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++C4+Therapeutics%2C+Inc.+++++For%3A+May+15/26504897.html Fri, 15 May 2026 16:05:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499890.html si-local-file:///var/storage/secattach/20260515/26499890.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499890.html Fri, 15 May 2026 08:10:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499890.html si-local-file:///var/storage/secattach/20260515/26499890.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++C4+Therapeutics%2C+Inc.++++++++++++++++++Filed+by%3A+Sirenia+Capital+Management+LP/26499890.html Fri, 15 May 2026 08:10:00 -0400 CCCC O.48629524 http://www.streetinsider.com/Earnings/C4+Therapeutics%2C+Inc.+%28CCCC%29+Tops+Q1+EPS+by+5c/26472981.html <p>C4 Therapeutics, Inc. (NASDAQ: CCCC) reported Q1 EPS of ($0.20), $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $6.15 million versus the consensus estimate of $4.8 million.</p><p>For earnings history and earnings-related data on C4 Therapeutics, Inc. (CCCC) <a href="http://www.streetinsider.com/ec_earnings.php?q=CCCC">click here</a>.</p> http://www.streetinsider.com/Earnings/C4+Therapeutics%2C+Inc.+%28CCCC%29+Tops+Q1+EPS+by+5c/26472981.html Tue, 12 May 2026 07:20:25 -0400 CCCC http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++C4+Therapeutics%2C+Inc.+++++For%3A+Mar+31/26472921.html si-local-file:///var/storage/secattach/20260512/26472921.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++C4+Therapeutics%2C+Inc.+++++For%3A+Mar+31/26472921.html Tue, 12 May 2026 07:08:00 -0400 CCCC O.48629524 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++C4+Therapeutics%2C+Inc.+++++For%3A+Mar+31/26472921.html si-local-file:///var/storage/secattach/20260512/26472921.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++C4+Therapeutics%2C+Inc.+++++For%3A+Mar+31/26472921.html Tue, 12 May 2026 07:08:00 -0400 CCCC O.48629524